Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about TKPHF Recent news which mentions TKPHF Takeda Moves Out From Licensing Agreement With Theravance Biopharma May 11, 2023 Tickers TAK TBPH TKPHF Tags Market News Benzinga Trading Ideas From Benzinga Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues May 11, 2023 Tickers TAK TKPHF Tags Earnings Movers Pre/Market Outlook From Benzinga United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review April 21, 2023 Tickers GSK MRK SNY TAK Tags TKPHF Government General From Benzinga Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says March 20, 2023 Tickers BMY TAK TKPHF Tags Biotech Large Cap BMY From Benzinga Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients February 21, 2023 Tickers TAK TKPHF Tags Health Care General TKPHF From Benzinga Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged February 02, 2023 Tickers TAK TKPHF Tags Eurasia Biotech Large Cap From Benzinga Why Shares of Phathom Pharmaceutical Jumped This Week January 28, 2023 Tickers PHAT TKPHF Tags PHAT Market News Recent Press Releases From Motley Fool Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study January 09, 2023 Tickers ARWR TAK TKPHF Tags Movers Briefs News From Benzinga Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B December 13, 2022 Tickers TAK TKPHF Tags Movers News Contracts From Benzinga Takeda's Dengue Vaccine Candidate Under FDA Priority Review November 23, 2022 Tickers TAK TKPHF Tags TKPHF TAK Benzinga From Benzinga Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings November 17, 2022 Tickers PBYI TAK TKPHF Tags TKPHF Health Care General From Benzinga Takeda Posts Lower 1H Profit, Lifts FY22 Outlook October 27, 2022 Tickers TAK TKPHF Tags Market News Guidance Benzinga From Benzinga Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids October 05, 2022 Tickers TAK TKPHF Tags Market News TAK FDA From Benzinga With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report August 30, 2022 Tickers GSK MRK SNY TAK Tags TKPHF General Health Care From Benzinga After Six Years Of Collaboration, Takeda Walks Away From Microbiome Drug Pact August 26, 2022 Tickers FNCH TAK TKPHF Tags News Contracts Briefs From Benzinga EXCLUSIVE: Takeda's Cancer Partner BridGene Raises $38.5M To Accelerate Work On Undruggable Targets July 27, 2022 Tickers TAK TKPHF Tags News Biotech TKPHF From Benzinga Takeda Touts Encouraging Data For Hyqvia In Rare Nerve Inflammation Disorder July 21, 2022 Tickers TAK TKPHF Tags Market News Benzinga TAK From Benzinga Takeda's Hereditary Angioedema Treatment Prevents Attacks In Kids Below 12 Years July 01, 2022 Tickers TAK TKPHF Tags Market News TAK Benzinga From Benzinga Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make May 17, 2022 Tickers BMY ETSY EXEL IPSEY Tags IPSEY TKPHF ISRG From Motley Fool Takeda Pharma Clocks 1% Increase In FY21 Core Profit, Expects Growth Momentum In FY22 May 11, 2022 Tickers TAK TKPHF Tags Market News Guidance Benzinga From Benzinga Takeda's Maribavir Reduces Hospitalization Rates, Hospital Stay In Post-Transplant Infection Patients April 22, 2022 Tickers TAK TKPHF Tags Market News TAK Benzinga From Benzinga Takeda's Angioedema Drug Shows Promising Action Against COVID-19 Infection March 08, 2022 Tickers TAK TKPHF Tags News Briefs Biotech From Benzinga Roche And AstraZeneca Settle Ultomiris Patent Lawsuit February 22, 2022 Tickers AZN AZNCF RHHBY TAK Tags AZNCF Market News TAK From Benzinga Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics February 22, 2022 Tickers TAK TKPHF Tags Contracts News gene therapy From Benzinga Real-World Analysis Show Takeda's Alofisel Clinical Remission Rate At Six-Months February 18, 2022 Tickers TAK TKPHF Tags Benzinga TAK Crohn's Disease From Benzinga FDA Approves Takeda's Vonvendi As Prophylactic Treatment In Bleeding Disorder January 31, 2022 Tickers TAK TKPHF Tags Biotech Briefs News From Benzinga FDA Rejects Takeda's Eosinophilic Esophagitis Candidate, Asks For Additional Study December 22, 2021 Tickers TAK TKPHF Tags TAK FDA Benzinga From Benzinga Novavax Files For Approval Of Its COVID-19 Vaccine In Japan December 16, 2021 Tickers NVAX TAK TKPHF Tags TKPHF General COVID/19 Coronavirus From Benzinga Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection November 24, 2021 Tickers TAK TKPHF Tags Market News TAK Benzinga From Benzinga Takeda, Shattuck Labs Terminate Immuno-Oncology Pact November 09, 2021 Tickers STTK TAK TKPHF Tags Market News Trading Ideas TAK From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.